Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
This is one part of a larger plan, so see how medically supervised peptide therapy at Perfect B in Doral works and how each protocol fits a complete, monitored plan
Who should avoid GHK-CU Wilson's disease or copper metabolism disorders Active malignancies (until more research exists) Pregnancy and breastfeeding Known copper sensitivity or allergy Those unable to maintain sterile injection technique When uncertain, consult a healthcare provider familiar with peptide research
(Current Lot will expire: 01/2028) 0.10% - 3.00% 2.00% Add at last step
Key areas of investigation include modulation of the nitric oxide (NO) system through interaction with NOS isoforms, upregulation of growth factor receptors (including VEGFR2 and EGF receptor systems), and engagement of the FAK-paxillin signaling cascade associated with cell migration and adhesion
The additional copper delivery from GHK-Cu could worsen dangerous copper buildup in those with this condition
